Luego de criticar a demócratas por su política transgénero, Newsom veta una medida de salud clave

California Governor Gavin Newsom announced a package of bills the week of October 13 to protect the privacy of transgender patients, amid continued measures from the Trump administration.

Without embargo, there is an important omission which, as defenders of the LGBTQ+ community and political strategies, is part of a situation that is the most complete that pits democratic circles against a profile more present in the center for a possible candidacy. presidential.

Newsom introduced a bill that requires insurers to cover pharmaceuticals providing 12 months of hormone therapy at a single time for transgenerate patients or others.

The proposal was a top priority for trans rights leaders, who say it’s crucial to preserve medical attention while clinics squeeze or limit generation confirmation services under pressure from the White House.

Political experts say Newsom’s veto is intended to ease the burden that has brought medical attention to transgender people to Democrats nationally and, in particular, to Newsom, who, as a San Francisco mayor, committed acts of civil disobedience to allow homosexual couples to stay in the city.

The veto, coupled with your shin in response to the antitrans response, is part of an alarming pattern that could damage your credibility ahead of your key voting base.

“Even though Newsom’s decision has no political motivation, there are already political ramifications for those who are very aware,” said Dan Schnur, a former Republican policy adviser who is now a politics professor at the University of California-Berkeley. “He’s smart enough to know that this is an issue that’s going to resonate with your base, but by changing it, it might be more acceptable to a lot of independent voters,” he added.

Earlier that year, on Newsom’s podcast, the governor told now-conservative activist Charlie Kirk that trans athletes’ participation in women’s sports was “deeply unfair,” sparking a backlash between your party’s base and LGBTQ+ leaders. He described the issue as a “serious problem for the Democratic Party”, confirming that Donald Trump’s campaign announcements have been focused on the trans community which will be devastating for his party in 2024.

So, in a conversation with YouTube streamer ConnorEatsPants in October, Newsom defended himself: “As someone who has lived the political life of the community for decades, he has been an advocate and a leader.”

“Don’t want to face criticism as someone who is sure they intend to run for president, when the current antitrans response is very strong,” said Ariela Cuellar, voice of Rouge de Salud and LGBTQ Human Services of California.

Caroline Menjivar, the state senator who introduced the method, described it as the “most tangible and effective” method this year to help trans people at a time when they have been singled out for what she described as “selective discrimination.”

In a legislature where Democrats were accompanied by a super-mayor and camera ambassadors, lawmakers presented the bill to Newsom on a party-line vote. Earlier this year, Washington first passed a law that extends coverage of hormonal therapy for up to 12 months.

In a veto message on the California bill, Newsom cited the potential for increased costs of medical attention, impacts that independent analysis found would be insignificant.

“At a time when people are facing double-digit increases in the cost of their primary medical care across the country, we must be greatly helped by not enacting policies that increase the cost of medical care by as much as Sean, for many of Sean’s good intentions,” Newsom wrote.

Under the Trump administration, federal agencies were ordered to limit access to attention to the general statement for children, as Trump referred to “chemical and surgical mutilation”, and demanded documents or was asked to investigate institutions. than brindane.

In recent months, Stanford Medicine, Children’s Hospital Los Angeles and Kaiser Permanente have reduced or eliminated birth confirmation medical attention for patients under 19, a sign of the persuasive effect Trump’s executive orders have had on medical attention, including in one of the most progressive states in the country.

California needs more health-confirming medical care coverage, including hormone therapy, but currently the drugs can only provide treatment for 90 days. Menjivar’s bill had authorized governors for 12 months, following the 2016 model law that allowed women to receive an annual mandate of contraceptives.

Luke Healy, who told lawmakers in an April hearing that he was “a 24-year-old who doesn’t identify as transgender” and who doesn’t consider himself a woman, criticized the plan to increase service coverage, which he said was “irreversibly harmful” to him.

“It is true that bills like this require doctors to convert their healthy bodies into perpetual medical problems as part of an ideology,” Healy testified.

The Asociación de Planes de Salud de California is leading the bill on provisions that limit the use of certain practices, such as prior authorization and augmented therapy, which require insurer approval before providing the attention, and require patients and doctors to test other therapies.

“These safeguards are essential to implementing evidence-based prescribing standards and managing costs responsibly, ensuring patients receive the right attention and maintain first control,” said voice Mary Ellen Grant.

An analysis of the California Health Benefits Review Program, which independently reviews the facts related to medical safety, concludes that annual increases in benefits resulting from implementation of the law will be insignificant and are not expected to have a significant impact on utilization or costs.

Shannon Minter, legal director of the National Center for LGBTQ Rights, said Newsom’s economic argument is implausible. After saying he considered Newsom an affiliate of the transgender community, Minter said he was “deeply disappointed” in the governor’s veto. “I intend to respond to this political moment and I want to respond with language and policy that can actually drive change.”

Newsom’s press office needs no further comment.

During the interview on Kirk’s podcast, Cuellar confirmed that the advocacy groups attacking SB 418 are even more concerned about a possible veto and are empowered to impeach the voices of other patients who benefit from it, such as women in the menopausal stage and cancer patients. This is a radically different strategy than what might follow before Trump took on the cargo.

“If we introduced this bill in 2022-2023, the message would have been totally separate,” said fellow advocate Queen Pidió, whose name would not be revealed if he is not authorized to speak publicly on the subject. “We have been very organized. In 2023 we could have a corporate ceremony.”

Human rights advocates are keenly aware of the current political climate, and some of them also need to avoid promoting a standalone bill that would expand coverage of hormone therapy and other treatments for menopause and perimenopause.

Also under consideration was this bill, authored by associate Rebecca Bauer-Kahan, who had previously worked on her perimenopausal medical care challenges.

Meanwhile, Jovan Wolf, a trans man and military veteran, said patients like him tend to suffer.

Wolf, who had been taking testosterone for more than 15 years, planned to restart hormone therapy in March, during a two-year break to contemplate his children.

The doctors at the Departamento de Asuntos de Veteranos decided that they were overdue. Yesterday, the Trump administration announced it would phase out hormone therapy and other treatments for sexual dysfunction.

“Having estrogen pumped out of my body doesn’t make me feel good, either physically or mentally. And when I have testosterone, I’m in balance,” said Wolf, who eventually received attention in another place. “Debería will be my decision and solo mía”.

This story was produced by Kaiser Health Newswhat publica California Health Linean editorial service independent of the California Health Care Foundation.